» Articles » PMID: 27454813

Sustained-release Drug Delivery of Antimicrobials in Controlling of Supragingival Oral Biofilms

Overview
Publisher Informa Healthcare
Specialty Pharmacology
Date 2016 Jul 26
PMID 27454813
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Dental caries, a bacterial biofilm-associated disease, is a prevalent oral health problem. It is a bacterial biofilm-associated disease. Conventional means of combating this disease involves oral hygiene, mostly tooth brushing. Supplementary means of prevention and treatment is often necessary. The use of sustained-release delivery systems, locally applied to the oral cavity appears to be one of the most acceptable avenues for the delivery of antimicrobial agents. Area covered: The development and current approaches of local sustained delivery technologies applied to the oral cavity for treatment and prevention of dental caries is discussed. The use of polymeric drug delivery systems, varnishes, liposomes and nanoparticles is presented. Expert opinion: The use of local sustained-release delivery systems applied to the oral cavity has numerous clinical, pharmacological and toxicological advantages over conventional means. Various sustained-release technologies have been suggested over the course of several years. The current research on oral diseases concentrates predominantly on improving the drug delivery. With progress in pharmaceutical technology, sophisticated controlled-release platforms are being developed. The sustained release concept is innovative and there are few products available for the benefit of all populations. Harmonizing academic research with the dental industry will surely expedite the development and commercialization of more products of such pharmacological nature.

Citing Articles

A Descriptive Review on the Potential Use of Diatom Biosilica as a Powerful Functional Biomaterial: A Natural Drug Delivery System.

Kang S, Woo Y, Seo Y, Yoo D, Kwon D, Park H Pharmaceutics. 2024; 16(9).

PMID: 39339207 PMC: 11434644. DOI: 10.3390/pharmaceutics16091171.


Polyglactin 910 Meshes Coated with Sustained-Release Cannabigerol Varnish Inhibit Biofilm Formation and Macrophage Cytokine Secretion: An In Vitro Study.

Abudalu M, Aqawi M, Sionov R, Friedman M, Gati I, Munz Y Pharmaceuticals (Basel). 2023; 16(5).

PMID: 37242528 PMC: 10221007. DOI: 10.3390/ph16050745.


Sinonasal Stent Coated with Sustained-Release Varnish of Mometasone Furoate Inhibits Pro-Inflammatory Cytokine Release from Macrophages: An In Vitro Study.

Cataldo Russomando A, Steinberg D, Gati I, Sionov R, Eliashar R, Friedman M Pharmaceutics. 2023; 15(3).

PMID: 36986875 PMC: 10051169. DOI: 10.3390/pharmaceutics15031015.


New Technological Approaches for Dental Caries Treatment: From Liquid Crystalline Systems to Nanocarriers.

Luiz M, Di Filippo L, Dutra J, Viegas J, Silvestre A, Anselmi C Pharmaceutics. 2023; 15(3).

PMID: 36986624 PMC: 10054708. DOI: 10.3390/pharmaceutics15030762.


Prolonged Inhibition of Growth and Biofilm Formation by Sustained Release of Chlorhexidine from Varnish Coated Dental Abutments: An Study.

Feldman M, Moustafa Elsayed W, Friedman M, Gati I, Steinberg D, Marei H Int J Dent. 2022; 2022:7246155.

PMID: 36275203 PMC: 9586801. DOI: 10.1155/2022/7246155.